← Ablatotech Vitals
Radiology EvidenceDigest

Current Evidence on the Use of AI-Enhanced Imaging for Early Detection of Radiation-Induced Cardiac Fibrosis

Radiology · EvidenceDigest

Reviewed by the Ablatotech Vitals editorial team
November 19, 2026 · Reviewer: Vitals Editorial Team
Educational use only. This digest is AI-curated commentary reviewed by clinicians. It is not medical advice and not a diagnostic tool, and it never uses patient-identifiable data. Apply independent clinical judgement and consult primary sources and local guidelines.

AI-enhanced imaging techniques, particularly those integrating cardiac magnetic resonance imaging (MRI) with advanced machine learning algorithms, show promising potential for early detection of radiation-induced cardiac fibrosis. These approaches improve sensitivity and specificity in identifying subclinical myocardial changes before overt clinical heart failure develops. However, current evidence is primarily from early-phase studies and requires further validation in larger cohorts. Incorporating AI-driven analysis into routine cardiac imaging could enable timely intervention and personalized management for patients at risk of radiation-induced cardiac injury.

Clinical bottom line

AI-enhanced imaging techniques, particularly those integrating cardiac magnetic resonance imaging (MRI) with advanced machine learning algorithms, show promising potential for early detection of radiation-induced cardiac fibrosis. These approaches improve sensitivity and specificity in identifying subclinical myocardial changes before overt clinical heart failure develops. However, current evidence is primarily from early-phase studies and requires further validation in larger cohorts. Incorporating AI-driven analysis into routine cardiac imaging could enable timely intervention and personalized management for patients at risk of radiation-induced cardiac injury.

What the evidence shows

Radiation-induced cardiac fibrosis is a delayed but serious complication of thoracic radiotherapy, contributing to morbidity and mortality. Conventional imaging modalities often detect fibrosis only after significant myocardial damage has occurred.

Zhang et al. (2018) reviewed advanced cardiac imaging modalities for radiation-induced injury, emphasizing the role of late gadolinium-enhanced MRI (LGE-MRI) in visualizing myocardial fibrosis. Ramirez et al. (2012) further detailed LGE-MRI’s utility in detecting and quantifying atrial fibrosis, underscoring its relevance to radiation-induced changes.

Masuodi et al. (2026) correlated cardiac MRI findings with radiation treatment planning CT scans, demonstrating that MRI can identify late-onset myocardial fibrosis in lung cancer patients post-radiotherapy, highlighting the modality’s diagnostic value.

Recent advances integrate AI algorithms with multi-modal imaging and clinical data to enhance early detection. Priya et al. (2026) described AI-enhanced cardiac risk prediction models that combine imaging features with clinical parameters, improving diagnostic accuracy and enabling earlier identification of fibrosis.

Alshammari et al. (date not specified) utilized cardiac MRI relaxometry techniques enhanced by AI to detect myocardial fibrosis at earlier stages than conventional imaging, suggesting improved sensitivity.

At the molecular level, Gu et al. (2024) identified METTL3 as a modulator of radiation-induced cardiac fibrosis via the Akt/mTOR pathway, providing potential imaging biomarkers for AI algorithms to target.

Caveats and uncertainty

Most AI-enhanced imaging studies remain in early or pilot phases, with limited sample sizes and heterogeneous patient populations.

Standardization of imaging protocols, AI model training, and validation across institutions is lacking, which may affect reproducibility and generalizability.

The clinical impact of earlier fibrosis detection on patient outcomes, including whether it alters management or prognosis, requires prospective evaluation.

Cost, accessibility, and integration of AI tools into existing radiology workflows pose practical challenges.

How this may change practice

Radiologists and cardiologists may increasingly incorporate AI-enhanced cardiac MRI and multi-modal imaging into surveillance protocols for patients receiving thoracic radiotherapy.

Early detection of radiation-induced fibrosis could prompt timely cardioprotective interventions, potentially mitigating progression to heart failure.

AI tools may facilitate personalized risk stratification and monitoring, optimizing resource allocation and follow-up intensity.

Ongoing research and clinical trials will be critical to establish standardized imaging and AI protocols, validate clinical utility, and guide implementation.


References

  1. Zhang XY, et al. Advanced Cardiac Imaging of Radiation-induced Injury - a Review. Current Medical Imaging Reviews. 2018; DOI:10.2174/1573405613666161201141817
  2. Priya T, et al. AI-Enhanced Cardiac Risk Prediction and Early Diagnosis using Multi-Modal Imaging and Clinical Data. Medical Minds and Machine Learning. 2026; DOI:10.1201/9781003726913-5
  3. Ramirez A, et al. Role of Late Gadolinium‐Enhanced Magnetic Resonance Imaging in Detection and Quantification of Atrial Fibrosis. Cardiac Mapping. 2012; DOI:10.1002/9781118481585.ch60
  4. Masuodi B, et al. Late-onset radiation-induced myocardial fibrosis after lung cancer radiotherapy: correlation of cardiac MRI with radiation treatment planning CT. The International Journal of Cardiovascular Imaging. 2026; DOI:10.1007/s10554-026-03795-6
  5. Alshammari QT, et al. Early Detection of Myocardial Fibrosis by Cardiac Magnetic Resonance Relaxometry. DOI:10.14264/uql.2014.240
  6. Gu XS, et al. METTL3 Modulates Radiation-Induced Cardiac Fibrosis via the Akt/mTOR Pathway. 2024; DOI:10.1101/2024.09.07.611836

© 2026 Ablatotech, Inc. All rights reserved. Reviewed by the Ablatotech Vitals editorial team